Chinook Therapeutics
Why Robinhood?
You can watch KDNY and buy or sell other stocks, ETFs, and their options commission-free!About KDNY
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
KDNY Key Statistics
Stock Snapshot
As of today, Chinook Therapeutics(KDNY) shares are valued at $40.39. The company's market cap stands at 2.9B, with a P/E ratio of -11.49.
Chinook Therapeutics(KDNY) stock opened on 2026-02-09 at —. The price climbed to — and dipped to —.
The Chinook Therapeutics(KDNY)'s current trading volume is 0, compared to an average daily volume of 1.98M.
During the past year, Chinook Therapeutics(KDNY) stock moved between $18.34 at its lowest and $40.51 at its peak.
During the past year, Chinook Therapeutics(KDNY) stock moved between $18.34 at its lowest and $40.51 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.